logo
ENTITY

FibroBiologics (FBLG US)

3
Analysis
Health Care • United States
FibroBiologics, Inc. operates as an early stage, cell therapy company. The Company develops food and drug administration trials related to fibroblast treatments for degenerative disc disease, multiple sclerosis, cancer, wound healing, and other diseases. FibroBiologics serves clients in the United States.
more
bullish•FibroBiologics
•22 Nov 2024 05:00•Issuer-paid

FBLG: On Target to Initiate Phase 1/2 Trial in 2025

On November 12, 2024, FibroBiologics, Inc. (FBLG) announced financial results for the third quarter of 2024 and provided a business update. The...

Logo
Share
bullish•FibroBiologics
•15 Aug 2024 03:00•Issuer-paid

FBLG: Proof-of-Concept Data for Artificial Thymus Technology

FibroBiologics is a cell therapy company focused on the development of fibroblast-based therapies for the treatment of chronic diseases with...

Logo
Share
bullish•FibroBiologics
•25 Jun 2024 12:49•Issuer-paid

FibroBiologics, Inc. - June 24, 2024

FibroBiologics is a cell therapy company focused on the development of fibroblast-based therapies for the treatment of chronic diseases with...

Logo
Share
No more insights

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x